ketanserin has been researched along with Impotence in 4 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated 3 agents with antiserotoninergic activity (oral trazodone, ketanserin and mianserin) in a double-blind randomized placebo controlled design in terms of the effectiveness in erectile dysfunction." | 5.07 | The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction. ( Altuğ, U; Erol, D; Germiyanoğlu, C; Gürdal, M; Kurt, U; Ozkardeş, H, 1994) |
| "The effects of monotherapy with once-daily ketanserin (40 mg) were compared to those of ketanserin (40 mg) plus hydrochlorothiazide (25 mg) once daily in 21 patients with mild essential hypertension." | 5.06 | Comparative antihypertensive effects of ketanserin and a ketanserin-hydrochlorothiazide combination administered once daily. ( Leary, WP; Maharaj, B; Reyes, AJ; van der Byl, K, 1987) |
| "From the beginning of the eighties papaverine was well established as the drug of choice for diagnosis and management of vasculogenic impotence." | 4.78 | [Endocavernous drug infusions revisited]. ( Bellorofonte, C; Dell'Acqua, S; Ferri, PM; Ruoppolo, M; Tagliaferri, A; Tombolini, P; Yamak, R; Zaatar, C, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurt, U | 1 |
| Ozkardeş, H | 1 |
| Altuğ, U | 1 |
| Germiyanoğlu, C | 1 |
| Gürdal, M | 1 |
| Erol, D | 1 |
| Bellorofonte, C | 2 |
| Dell'Acqua, S | 2 |
| Ruoppolo, M | 2 |
| Zaatar, C | 2 |
| Tombolini, P | 2 |
| Ferri, PM | 1 |
| Yamak, R | 1 |
| Tagliaferri, A | 1 |
| Leary, WP | 1 |
| Reyes, AJ | 1 |
| van der Byl, K | 1 |
| Maharaj, B | 1 |
1 review available for ketanserin and Impotence
| Article | Year |
|---|---|
[Endocavernous drug infusions revisited].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Ketanserin; Male; Papaverine; Penile Erection | 1991 |
2 trials available for ketanserin and Impotence
| Article | Year |
|---|---|
The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction.
Topics: Adult; Aged; Double-Blind Method; Erectile Dysfunction; Humans; Ketanserin; Male; Mianserin; Middle | 1994 |
Comparative antihypertensive effects of ketanserin and a ketanserin-hydrochlorothiazide combination administered once daily.
Topics: Blood Pressure; Drug Therapy, Combination; Erectile Dysfunction; Fatigue; Heart Rate; Humans; Hydroc | 1987 |
1 other study available for ketanserin and Impotence
| Article | Year |
|---|---|
[Intracavernous infusion of drugs].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Ketanserin; Male; Papaverine; Penis; Phentola | 1992 |